Skip to content

Influence of Meal Skipping on Macronutrient Oxidation and Glucose Metabolism Under Isocaloric Conditions

Influence of Meal Skipping on Macronutrient Oxidation and Glucose Metabolism Under Isocaloric Conditions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02635139
Enrollment
17
Registered
2015-12-18
Start date
2015-12-31
Completion date
2016-10-31
Last updated
2017-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

meal skipping, isocaloric diet, macronutrient oxidation, glucose homeostasis, arterial stiffness

Brief summary

Aim of the study is to investigate the impact of meal skipping (breakfast or dinner skipping) on the regulation of glucose metabolism and macronutrient balance (protein/fat/carbohydrate intake vs. -oxidation). An isoenergetic diet with 3 conventional meals (breakfast, lunch, dinner) serves as a control.

Detailed description

The duration of the study is 7 days including 3 days with controlled diet and 4 days (including 5 nights) in a metabolic chamber at the Institute of Nutritional Medicine at the University of Hohenheim. The study phase in the metabolic chamber consists of (i) 1 day with 3 meals/day = baseline day, (ii) 1 day with breakfast skipping, (iii) 1 day with dinner skipping, (iv) 1 washout day where the subjects leave the chamber between 7 a.m. until 7 p.m.. Beginning on the 3rd study day macronutrient and energy intake as well as the fasting periods are kept constant. To achieve comparable conditions the washout day is setted before the baseline day.

Interventions

18h fasting period in the morning

BEHAVIORALDinner skipping

18h fasting period in the evening

Sponsors

University of Hohenheim
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy * not obese (BMI\<30)

Exclusion criteria

* food allergy * smoking * alternative nutrition habits * chronic disease * regular medication intake * claustrophobia

Design outcomes

Primary

MeasureTime frame
Regulation of glucose metabolism (substrate oxidation and insulin sensitivity)1 day

Secondary

MeasureTime frame
Actigraphy-assessed sleep quality1 day
cardio vascular risk (lipid profile, arterial stiffness, autonomic function)1 day

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026